Our Pipeline and Products

Menarini is investing in advanced science and technology to develop a pipeline of new products that make a difference to the lives of patients affected by serious conditions.

MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.

Share your partnering idea

Our dedicated Corporate Business Development team is committed to assess and explore innovative new opportunities.

 

Donations of backpacks and cases for school, distribution of meals and medicines, promotion of sport, support for pregnant women and much more: being responsible for Menarini means transforming good intentions into concrete efforts. By helping others, we want to contribute to improve the world around us, starting with us.

Our Values

Everyday we put our values into action. 4 values, which have given life to Menarini and shaped its history.

 

What does it really make Menarini unique? The diversity and authenticity of our key resource - the People.
Our cultural diversity helps us to drive innovation, adapt to business changes, face challenges, inspire ideas and develop our growth.

Available positions on Linkedin

Menarini employees make all the difference, every day.

 

News

Berlin-Chemie Menarini’s position in Ukraine

We continue to be deeply concerned by the tragic situation in Ukraine, the devastating losses of civilians and the suffering of the entire Ukrainian population.

The below summarizes our actions and position:

For Ukraine, in addition to the original donation of Berlin-Chemie, the Menarini Group has added further financial donations and continuous medicines donations for a total contribution of over 1 Million euros by now.

In Russia, we stopped all advertising spend, ceased all new investments including research and manufacturing plant as well implementation of a headcount freeze in the entirety of our operation.

Currently, we are in a stall mode in Russia only supplying our medicines to patients who depend upon them in line with exemption of medicines from international sanctions. We are also one of the few pharma companies who still operate in Ukraine supplying our medicines to patients in need.

We stand with the Ukrainian people and hope for a peaceful resolution as soon as possible.